| Product Code: ETC7539056 | Publication Date: Sep 2024 | Product Type: Market Research Report | ||
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India cancer gene therapy market import shipment demonstrated a declining trend over the period 2020-2024, indicated by a negative CAGR of -1.7%. The market experienced a significant contraction in growth between 2023 and 2024, with a decline of -25.5%. This reflects a notable slowdown in market expansion, suggesting a challenging landscape for import shipments in the sector.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Cancer Gene Therapy Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Cancer Gene Therapy Market Revenues & Volume, 2021 & 2031F |
3.3 India Cancer Gene Therapy Market - Industry Life Cycle |
3.4 India Cancer Gene Therapy Market - Porter's Five Forces |
3.5 India Cancer Gene Therapy Market Revenues & Volume Share, By Therapy, 2021 & 2031F |
3.6 India Cancer Gene Therapy Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 India Cancer Gene Therapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in India |
4.2.2 Growing investments in research and development of gene therapy technologies |
4.2.3 Favorable government initiatives and policies supporting cancer treatment and gene therapy |
4.3 Market Restraints |
4.3.1 High cost associated with gene therapy treatments |
4.3.2 Limited awareness and acceptance of gene therapy among patients and healthcare professionals |
5 India Cancer Gene Therapy Market Trends |
6 India Cancer Gene Therapy Market, By Types |
6.1 India Cancer Gene Therapy Market, By Therapy |
6.1.1 Overview and Analysis |
6.1.2 India Cancer Gene Therapy Market Revenues & Volume, By Therapy, 2021- 2031F |
6.1.3 India Cancer Gene Therapy Market Revenues & Volume, By Gene Induced Immunotherapy, 2021- 2031F |
6.1.4 India Cancer Gene Therapy Market Revenues & Volume, By Oncolytic Virotherapy, 2021- 2031F |
6.1.5 India Cancer Gene Therapy Market Revenues & Volume, By Gene Transfer, 2021- 2031F |
6.2 India Cancer Gene Therapy Market, By End User |
6.2.1 Overview and Analysis |
6.2.2 India Cancer Gene Therapy Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.2.3 India Cancer Gene Therapy Market Revenues & Volume, By Diagnostic centers, 2021- 2031F |
6.2.4 India Cancer Gene Therapy Market Revenues & Volume, By Research Institutes, 2021- 2031F |
7 India Cancer Gene Therapy Market Import-Export Trade Statistics |
7.1 India Cancer Gene Therapy Market Export to Major Countries |
7.2 India Cancer Gene Therapy Market Imports from Major Countries |
8 India Cancer Gene Therapy Market Key Performance Indicators |
8.1 Number of clinical trials and research studies related to gene therapy in India |
8.2 Adoption rate of gene therapy treatments in cancer patients |
8.3 Number of gene therapy products approved for cancer treatment in India |
9 India Cancer Gene Therapy Market - Opportunity Assessment |
9.1 India Cancer Gene Therapy Market Opportunity Assessment, By Therapy, 2021 & 2031F |
9.2 India Cancer Gene Therapy Market Opportunity Assessment, By End User, 2021 & 2031F |
10 India Cancer Gene Therapy Market - Competitive Landscape |
10.1 India Cancer Gene Therapy Market Revenue Share, By Companies, 2024 |
10.2 India Cancer Gene Therapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |